University of Grenoble I, Department of Molecular Chemistry, UMR CNRS 5250, F-38041, Grenoble Cedex 9, France.
Anticancer Res. 2010 Jul;30(7):2553-9.
Iodinated derivatives of verapamil were synthesized and tested as P-glycoprotein (Pgp)-mediated multidrug resistance (MDR) reversal agents. The ability of these compounds to revert MDR was evaluated on daunorubicin-resistant K562 cells, by measuring the intracellular accumulation of rhodamine 123, a fluorescent probe of Pgp transport activity. One of the investigated compounds (16c) was found to be a more potent MDR reversal agent than verapamil and cyclosporin A, used as reference molecules. Further in vitro studies showed that compound 16c restored daunorubicin activity and, when used alone, did not induce cell death, cell cycle perturbation and modification of calcium channel activity in comparison with verapamil.
合成了维拉帕米的碘代衍生物,并将其作为 P 糖蛋白(Pgp)介导的多药耐药(MDR)逆转剂进行了测试。通过测量荧光探针 rhodamine 123 在多柔比星耐药 K562 细胞内的积累,评估这些化合物逆转 MDR 的能力,该探针可用于检测 Pgp 转运活性。研究发现,其中一种化合物(16c)比维拉帕米和环孢素 A(用作参考分子)更能有效逆转 MDR。进一步的体外研究表明,与维拉帕米相比,化合物 16c 可恢复多柔比星的活性,且单独使用时不会诱导细胞死亡、细胞周期紊乱和钙通道活性改变。